These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 16436234)

  • 1. Comment on "Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain".
    Friedman SD
    Science; 2008 Aug; 321(5889):640. PubMed ID: 18669845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
    Franczak M; Prost RW; Antuono PG; Mark LP; Jones JL; Ulmer JL
    J Comput Assist Tomogr; 2007; 31(5):666-70. PubMed ID: 17895774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
    Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proton magnetic resonance spectroscopy in the evaluation of cognitive disturbances].
    Mathiesen HK; Nielsen AS; Nielsen K; Hanson LG
    Ugeskr Laeger; 2006 Jan; 168(4):357-9. PubMed ID: 16436234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy in cognitive research.
    Ross AJ; Sachdev PS
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):83-102. PubMed ID: 15003387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of magnetic resonance spectroscopy in the study of brain disease].
    Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
    Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
    De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
    J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.
    Griffith HR; Stewart CC; den Hollander JA
    Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.
    Mason GF; Krystal JH
    NMR Biomed; 2006 Oct; 19(6):690-701. PubMed ID: 16986118
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.